Shuling Zhang

Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and/or tyrosine kinase domain mutations

Juan Cheng, Bei Liu, Jiangyun Zhao, 2018, International journal of laboratory hematology.

Outcome of patient with high-risk chronic myelomonocytic leukemia, treated with decitabine prior to transformation to acute myeloid leukemia: A case report

Juan Cheng, Qian Xu, Bei Liu, 2018, Oncology letters.

Comparison of existing prognostic models in chronic myelomonocytic leukemia

Bei Liu, Shuling Zhang, J. Jian, 2020, Chinese medical journal.

Concomitant isochromosome 17q and mutated SETBP1 in a myelodysplastic syndrome patient with a poor prognosis.

Huan Liu, Qian Xu, Bei Liu, 2017, International journal of clinical and experimental pathology.

Acute myeloid leukemia (AML)‐derived mesenchymal stem cells induce chemoresistance and epithelial–mesenchymal transition‐like program in AML through IL‐6/JAK2/STAT3 signaling

Qiao-mei Dong, Li Zhao, Shuling Zhang, 2023, Cancer science.

Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO

W. Zhou, Degui Wang, Shuili Yu, 2018, Leukemia and Lymphoma.

The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia

Lan-xia Zhou, Juan Cheng, Li Zhao, 2023, Journal of Cancer Research and Clinical Oncology.

Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT/mTOR.

Shuling Zhang, Jianle Lu, Jincai Yang, 2024, Anti-cancer drugs.